These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26598593)

  • 41. Bupropion: pharmacology and therapeutic applications.
    Foley KF; DeSanty KP; Kast RE
    Expert Rev Neurother; 2006 Sep; 6(9):1249-65. PubMed ID: 17009913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conformational analysis and a crystal structure of bupropion, an antidepressant with dopamine reuptake blocking activity.
    Froimowitz M; George C
    J Chem Inf Comput Sci; 1998; 38(3):506-10. PubMed ID: 9611786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions?
    Arias HR
    Int J Biochem Cell Biol; 2009 Nov; 41(11):2098-108. PubMed ID: 19497387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area.
    Mansvelder HD; Fagen ZM; Chang B; Mitchum R; McGehee DS
    Biochem Pharmacol; 2007 Oct; 74(8):1283-91. PubMed ID: 17868653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion . HCl--a new atypical antidepressant agent.
    Ferris RM; Maxwell RA; Cooper BR; Soroko FE
    Adv Biochem Psychopharmacol; 1982; 31():277-86. PubMed ID: 6282058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Change of dopamine transporter activity (DAT) during the action of bupropion (in depression)].
    Szabó Z; Argyelán M; Kanyó B; Pávics L; Janka Z
    Neuropsychopharmacol Hung; 2004 Jun; 6(2):79-81. PubMed ID: 15787205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Smoking cessation and bupropion: anxiety and depression as predictors of therapeutic efficacy].
    Sampablo Lauro I; Carreras JM; Lores L; Quesada M; Coll F; Sánchez Agudo L
    Arch Bronconeumol; 2002 Aug; 38(8):351-5. PubMed ID: 12199915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fatal bupropion overdose.
    Harris CR; Gualtieri J; Stark G
    J Toxicol Clin Toxicol; 1997; 35(3):321-4. PubMed ID: 9140330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bupropion sustained release treatment decreases craving for video games and cue-induced brain activity in patients with Internet video game addiction.
    Han DH; Hwang JW; Renshaw PF
    Exp Clin Psychopharmacol; 2010 Aug; 18(4):297-304. PubMed ID: 20695685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bupropion extended-release for depressive disorders.
    Jefferson JW
    Expert Rev Neurother; 2008 May; 8(5):715-22. PubMed ID: 18457528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.
    Thase ME; Clayton AH; Haight BR; Thompson AH; Modell JG; Johnston JA
    J Clin Psychopharmacol; 2006 Oct; 26(5):482-8. PubMed ID: 16974189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized, placebo-controlled trial of bupropion sustained release in chronic low back pain.
    Katz J; Pennella-Vaughan J; Hetzel RD; Kanazi GE; Dworkin RH
    J Pain; 2005 Oct; 6(10):656-61. PubMed ID: 16202958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.
    Dwoskin LP; Rauhut AS; King-Pospisil KA; Bardo MT
    CNS Drug Rev; 2006; 12(3-4):178-207. PubMed ID: 17227286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Falling backward in two elderly patients taking bupropion.
    Szuba MP; Leuchter AF
    J Clin Psychiatry; 1992 May; 53(5):157-9. PubMed ID: 1592841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monoarthritis Induced by Bupropion Hydrochloride.
    Yuan W; Williams BN
    Psychopharmacol Bull; 2011 May; 44(2):85-87. PubMed ID: 27738357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urinary Incontinence during Sleep Associated with Extended Release Form of Bupropion HCI.
    Izci F; Iris Koc M; Bilici R; Yalcin M; Bestepe EE
    Case Rep Psychiatry; 2015; 2015():906294. PubMed ID: 26613061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lithium and bupropion antagonise the phasic changes in locomotor activity caused by dopamine infused into the rat nucleus accumbens.
    Barnes JC; Costall B; Domeney AM; Naylor RJ
    Psychopharmacology (Berl); 1986; 89(3):311-6. PubMed ID: 3088656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bupropion and bupropion analogs as treatments for CNS disorders.
    Carroll FI; Blough BE; Mascarella SW; Navarro HA; Lukas RJ; Damaj MI
    Adv Pharmacol; 2014; 69():177-216. PubMed ID: 24484978
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bupropion diversion and misuse in the correctional facility.
    Hilliard WT; Barloon L; Farley P; Penn JV; Koranek A
    J Correct Health Care; 2013 Jul; 19(3):211-7. PubMed ID: 23788587
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review of bupropion for smoking cessation.
    Richmond R; Zwar N
    Drug Alcohol Rev; 2003 Jun; 22(2):203-20. PubMed ID: 12850907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.